Sotera Health (NASDAQ:SHC) Given Consensus Recommendation of “Moderate Buy” by Analysts

Sotera Health (NASDAQ:SHC) has received an average rating of “Moderate Buy” from the seven ratings firms that are presently covering the firm, MarketBeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month target price among brokers that have covered the stock in the last year is $16.08.

SHC has been the subject of a number of recent research reports. The Goldman Sachs Group assumed coverage on shares of Sotera Health in a report on Friday, December 6th. They issued a “neutral” rating and a $14.00 price objective for the company. Royal Bank of Canada reissued an “outperform” rating and set a $17.00 price objective on shares of Sotera Health in a report on Thursday, November 21st. Finally, Citigroup upped their target price on Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th.

Sotera Health Price Performance

Shares of NASDAQ:SHC opened at $13.49 on Friday. The business has a fifty day simple moving average of $13.88 and a 200 day simple moving average of $14.39. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 1 year low of $10.71 and a 1 year high of $17.44. The firm has a market cap of $3.82 billion, a price-to-earnings ratio of 53.96 and a beta of 1.92.

Sotera Health (NASDAQ:SHC) last announced its quarterly earnings results on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The firm had revenue of $285.47 million for the quarter, compared to analyst estimates of $278.64 million. During the same quarter in the prior year, the firm earned $0.18 earnings per share. The firm’s quarterly revenue was up 8.5% compared to the same quarter last year. As a group, sell-side analysts predict that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Sotera Health

Hedge funds have recently made changes to their positions in the stock. Darsana Capital Partners LP grew its position in Sotera Health by 716.9% in the third quarter. Darsana Capital Partners LP now owns 20,010,000 shares of the company’s stock valued at $334,167,000 after acquiring an additional 17,560,636 shares during the period. Sessa Capital IM L.P. increased its position in shares of Sotera Health by 46.5% during the 3rd quarter. Sessa Capital IM L.P. now owns 6,300,597 shares of the company’s stock worth $105,220,000 after purchasing an additional 2,000,000 shares in the last quarter. State Street Corp lifted its holdings in Sotera Health by 18.5% during the 3rd quarter. State Street Corp now owns 4,126,806 shares of the company’s stock valued at $68,918,000 after purchasing an additional 644,236 shares during the last quarter. Maverick Capital Ltd. boosted its position in Sotera Health by 3.5% in the third quarter. Maverick Capital Ltd. now owns 3,497,367 shares of the company’s stock valued at $58,406,000 after buying an additional 118,353 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in Sotera Health by 19.4% in the third quarter. Geode Capital Management LLC now owns 2,755,391 shares of the company’s stock valued at $46,026,000 after buying an additional 447,186 shares in the last quarter. Institutional investors own 91.03% of the company’s stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.